Equity Research Analysis: Cronos Group Inc. (CRON)
|Blank Capital Research Unit|Spot: $2.75
Price$2.75
Composite Score53.6/100
RatingHOLD (3★)
Rank#1448 OF 7,333
Market Cap$1.1B
Intelligence Feed
BenzingaDec 9 Positive
Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company
Cronos Group is acquiring CanAdelaar, the largest cannabis company in the Netherlands' adult-use cannabis pilot program, for $67 million upfront, with potential additional earnouts. The acquisition provides Cronos strategic entry into the European cannabis market and establishes a market leadership position.
yahooFeb 17 Negative
Cronos Launches New All-in-One Vape, Spinach PUFFERZ™
Spinach PUFFERZ™ delivers a flavorful experience combining high-quality cannabis with a sleek tactile design, enhanced with liquid diamonds Spinach PUFFERZ™ Spinach PUFFERZ™ Pineapple Coconut (Indica), Spinach PUFFERZ™ Sour Blue Razz (Hybrid), Spinach PUFFERZ™ Tropical AF (Sativa) TORONTO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced today the launch of its newest all-in-one (AIO) vape, Spinach PUFF
The Motley FoolJan 24 Neutral
Altria Group: Is This High-Yield Dividend Stock Too Cheap to Ignore?
Altria Group faces declining revenues despite its traditional strategy of raising prices to offset falling smoking rates. While the stock trades at an attractive P/E ratio of 12 with a 6.8% dividend yield, the company's failed investments in e-cigarettes (Juul, NJOY) and cannabis (Cronos Group) have cost billions. With dividend payments consuming most of its free cash flow, the company risks its ability to sustain dividend growth unless it reverses revenue declines.
The Motley FoolDec 16 Positive
Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification
Tilray Brands experienced a significant stock surge of 27.5% after President Trump suggested potentially reclassifying marijuana from Schedule I to Schedule III, which could expand the cannabis industry's market opportunities.
The Motley FoolOct 9 Negative
Could Buying Altria Today Set You Up for Life?
Altria offers a high 6.4% dividend yield, but faces significant challenges including declining cigarette volumes, unsuccessful diversification attempts, and strategic missteps that could threaten its long-term dividend sustainability.